XML 63 R39.htm IDEA: XBRL DOCUMENT v3.22.1
SEGMENT INFORMATION (Tables)
 3 Months Ended
Mar. 31, 2022
Segment Reporting [Abstract]  
Financial information regarding the Company's reportable segments
Financial information regarding our reporting segments is shown below:
Three Months Ended March 31,20222021
Total Sales:
Pharma$346,672 $315,811 
Beauty + Home374,475 353,377 
Food + Beverage134,767 116,703 
Total Sales$855,914 $785,891 
Less: Intersegment Sales:
Pharma$4,210 $1,979 
Beauty + Home6,276 6,431 
Food + Beverage496 727 
Total Intersegment Sales$10,982 $9,137 
Net Sales:
Pharma$342,462 $313,832 
Beauty + Home368,199 346,946 
Food + Beverage134,271 115,976 
Net Sales$844,932 $776,754 
Adjusted EBITDA (1):
Pharma$115,552 $108,484 
Beauty + Home39,498 35,356 
Food + Beverage19,235 19,990 
Corporate & Other, unallocated(17,970)(11,607)
Restructuring Initiatives (2)(291)(3,672)
Net unrealized investment (loss) gain (3)(2,091)16,809 
Depreciation and amortization(58,665)(57,438)
Interest Expense(8,930)(7,415)
Interest Income288 381 
Income before Income Taxes$86,626 $100,888 
________________________________________________
(1)We evaluate performance of our reporting segments and allocate resources based upon Adjusted EBITDA. Adjusted EBITDA is defined as earnings before net interest, taxes, depreciation, amortization, unallocated corporate expenses, restructuring initiatives, acquisition-related costs, net unrealized investment gains and losses related to observable market price changes on equity securities and other special items.
(2)Restructuring Initiatives includes expense items for the three months ended March 31, 2022 and 2021 as follows (see Note 18 – Restructuring Initiatives for further details):
Three Months Ended March 31,20222021
Restructuring Initiatives by Segment
Pharma$— $35 
Beauty + Home258 1,096 
Food + Beverage33 (79)
Corporate & Other— 2,620 
Total Restructuring Initiatives$291 $3,672 
(3)Net unrealized investment (loss) gain represents the change in fair value of our investment in PCT (see Note 17 – Investment in Equity Securities for further details).
Restructuring Initiatives Restructuring Initiatives includes expense items for the three months ended March 31, 2022 and 2021 as follows (see Note 18 – Restructuring Initiatives for further details):
Three Months Ended March 31,20222021
Restructuring Initiatives by Segment
Pharma$— $35 
Beauty + Home258 1,096 
Food + Beverage33 (79)
Corporate & Other— 2,620 
Total Restructuring Initiatives$291 $3,672